Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vincera Pharma, Inc.

0.6306
-0.0885-12.31%
Post-market: 0.64000.0094+1.49%16:41 EDT
Volume:972.49K
Turnover:622.83K
Market Cap:1.41M
PE:-0.04
High:0.7000
Open:0.6687
Low:0.5910
Close:0.7191
Loading ...

BUZZ-Vincerx Pharma soars on QumulusAI merger deal

Reuters
·
18 Mar

Vincerx Pharma Plans Reverse Merger With AI Infrastructure Firm QumulusAI

MT Newswires
·
18 Mar

Vincerx Pharma : as of Feb 28, 2025, Had About$3.9 Mln in Cash and Anticipates Its Cash Runway Will Extend Into Late Q2 2025

THOMSON REUTERS
·
18 Mar

Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination With Qumulusai

THOMSON REUTERS
·
18 Mar

Vincerx Pharma Inc - Qumulusai Equity Holders to Own 95% of Combined Company

THOMSON REUTERS
·
18 Mar

Vincerx Pharma Inc - Qumulusai to Become Publicly Traded Through Reverse Triangular Merger

THOMSON REUTERS
·
18 Mar

Press Release: Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI

Dow Jones
·
18 Mar

Vincerx Pharma Terminates Reverse Merger Deal With Oqory

Dow Jones
·
01 Mar

BRIEF-Vincerx Pharma Announces Termination Of Reverse Merger Term Sheet

Reuters
·
01 Mar

Vincerx Pharma announces termination of reverse merger term sheet

TIPRANKS
·
01 Mar

Vincerx Pharma Inc trading halted, news pending

TIPRANKS
·
01 Mar

Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives

THOMSON REUTERS
·
01 Mar

Vincerx Pharma Inc - Cash Runway Expected to Extend Through Late Q2 2025

THOMSON REUTERS
·
01 Mar

Press Release: Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives

Dow Jones
·
01 Mar

BRIEF-Vincerx Pharma Regains Compliance With Nasdaq Listing Rule 5550(A)(2)

Reuters
·
19 Feb

Vincerx Pharma Inc - Regains Compliance With Nasdaq Listing Rule 5550(a)(2)

THOMSON REUTERS
·
19 Feb